Institute MECHNIKOV, created as part of the Russian and Nicaraguan project in Managua, began production of commercial batches of influenza vaccine. April 10. Managua. Institute MECHNIKOV has launched the production of a commercial vaccine batches in Managua (Nicaragua). The launch of the production lines was attended by the advisor for investments of the Government of
On October 22, 2016 Managua, the capital of Nicaragua, hosted an official event celebrating the construction completion of Latin America’s first immunobiological vaccine factory – Mechnikov. The ceremony was attended by the Minister of Health of Russia Ms. V.I. Skvortsova, Head of FMBA of Russia Mr. V.V. Uiba, PAHO/WHO Director Ms. Carissa F. Etienne, Director
The influenza vaccine, developed by the St. Petersburg Research Institute of Vaccines and Serums of the Russian Federal Biomedical Agency, was issued a registration certificate in Nicaragua. This is the first step in the joint project by the Russian-Nicaraguan Intergovernmental Commission to support penetration by Russian immunobiological products of the Latin American markets. The registration
flu
In Krasnoselsky District of St. Petersburg, a new one-of-a-kind full cycle production line of influenza vaccines using a unique incubation process opened at the St. Petersburg Scientific Research Institute of Vaccines and Serums (SPbSRIVS) of the Federal Biomedical Agency. The ceremony was opened by the Minister of Health of the Russian Federation Ms. Veronika Skvortsova: